Related references
Note: Only part of the references are listed.Testosterone supplementation and body composition: results from a meta-analysis study
Giovanni Corona et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2016)
The safety and efficacy of Avanafil, a new 2nd generation PDE5i: comprehensive review and meta- analysis
Giovanni Corona et al.
EXPERT OPINION ON DRUG SAFETY (2016)
Results from an online survey investigating ED patients' insights and treatment expectations
A. Burri et al.
INTERNATIONAL JOURNAL OF IMPOTENCE RESEARCH (2015)
Obesity and late-onset hypogonadism
G. Corona et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2015)
An integrated approach with vardenafil orodispersible tablet and cognitive behavioral sex therapy for treatment of erectile dysfunction: a randomized controlled pilot study
V. Boddi et al.
ANDROLOGY (2015)
Erectile dysfunction and central obesity: an Italian perspective
Giovanni Corona et al.
ASIAN JOURNAL OF ANDROLOGY (2014)
Is chronic inhibition of phosphodiesterase type 5 cardioprotective and safe? A meta-analysis of randomized controlled trials
Elisa Giannetta et al.
BMC MEDICINE (2014)
A Critical Analysis of the Role of Testosterone in Erectile Function: From Pathophysiology to Treatment-A Systematic Review
Andrea M. Isidori et al.
EUROPEAN UROLOGY (2014)
Injectable testosterone undecanoate for the treatment of hypogonadism
Giovanni Corona et al.
EXPERT OPINION ON PHARMACOTHERAPY (2014)
Continuation and effectiveness of tadalafil once daily during a 6-month observational study in erectile dysfunction: the EDATE study
J. Buvat et al.
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (2014)
Reasons and predictive factors for discontinuation of PDE-5 inhibitors despite successful intercourse in erectile dysfunction patients
S-C Kim et al.
INTERNATIONAL JOURNAL OF IMPOTENCE RESEARCH (2014)
Data on the utilization of treatment modalities for ED in Taiwan in the era of PDE5 inhibitors
W-K Tsai et al.
INTERNATIONAL JOURNAL OF IMPOTENCE RESEARCH (2014)
Sexual Dysfunction at the Onset of Type 2 Diabetes: The Interplay of Depression, Hormonal and Cardiovascular Factors
Giovanni Corona et al.
JOURNAL OF SEXUAL MEDICINE (2014)
Testosterone Supplementation and Sexual Function: A Meta-Analysis Study
Giovanni Corona et al.
JOURNAL OF SEXUAL MEDICINE (2014)
Management of ED under the Severe Distress Criteria in the NHS: A Real-Life Study
Amar Mohee et al.
JOURNAL OF SEXUAL MEDICINE (2014)
PDE5 Inhibitor Treatment Persistence and Adherence in Brazilian Men: Post-hoc Analyses from a 6-Month, Prospective, Observational Study
Carlos Cairoli et al.
INTERNATIONAL BRAZ J UROL (2014)
The SIAMS-ED Trial: A National, Independent, Multicentre Study on Cardiometabolic and Hormonal Impairment of Men with Erectile Dysfunction Treated with Vardenafil
Andrea M. Isidori et al.
INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (2014)
Diagnosis and treatment of late-onset hypogonadism: Systematic review and meta-analysis of TRT outcomes
G. Corona et al.
BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM (2013)
Sexual function of the ageing male
Giovanni Corona et al.
BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM (2013)
Prediction of Cardiovascular Events and All-Cause Mortality With Erectile Dysfunction A Systematic Review and Meta-Analysis of Cohort Studies
Charalambos V. Vlachopoulos et al.
CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES (2013)
A 6-month, prospective, observational study of PDE5 inhibitor treatment persistence and adherence in Middle Eastern and North African men with erectile dysfunction
Amr El-Meliegy et al.
CURRENT MEDICAL RESEARCH AND OPINION (2013)
IPASS: A Study on the Tolerability and Effectiveness of Injectable Testosterone Undecanoate for the Treatment of Male Hypogonadism in a Worldwide Sample of 1,438 Men
Michael Zitzmann et al.
JOURNAL OF SEXUAL MEDICINE (2013)
Adherence to Initial PDE-5 Inhibitor Treatment: Randomized Open-Label Study Comparing Tadalafil Once a Day, Tadalafil on Demand, and Sildenafil on Demand in Patients with Erectile Dysfunction
Jacques Buvat et al.
JOURNAL OF SEXUAL MEDICINE (2013)
SOP Conservative (Medical and Mechanical) Treatment of Erectile Dysfunction
Hartmut Porst et al.
JOURNAL OF SEXUAL MEDICINE (2013)
Risk Factors Associated with Primary and Secondary Reduced Libido in Male Patients with Sexual Dysfunction
Giovanni Corona et al.
JOURNAL OF SEXUAL MEDICINE (2013)
Stable extramarital affairs are breaking the heart
A. D. Fisher et al.
INTERNATIONAL JOURNAL OF ANDROLOGY (2012)
It Takes Two to Tango: The Relational Domain in a Cohort of Subjects with Erectile Dysfunction (ED)
Valentina Boddi et al.
JOURNAL OF SEXUAL MEDICINE (2012)
SIEDY Scale 3, a New Instrument to Detect Psychological Component in Subjects with Erectile Dysfunction
Giovanni Corona et al.
JOURNAL OF SEXUAL MEDICINE (2012)
Dropout in the Treatment of Erectile Dysfunction with PDE5: A Study on Predictors and a Qualitative Analysis of Reasons for Discontinuation
Ana A. Carvalheira et al.
JOURNAL OF SEXUAL MEDICINE (2012)
Sexual and Cardiovascular Correlates of Male Unfaithfulness
Alessandra D. Fisher et al.
JOURNAL OF SEXUAL MEDICINE (2012)
Erectile Dysfunction and Cardiovascular Events in Diabetic Men: A Meta-analysis of Observational Studies
Tomohide Yamada et al.
PLOS ONE (2012)
The Effect of Lifestyle Modification and Cardiovascular Risk Factor Reduction on Erectile Dysfunction A Systematic Review and Meta-analysis
Bhanu P. Gupta et al.
ARCHIVES OF INTERNAL MEDICINE (2011)
Sildenafil for Erectile Dysfunction in the Middle East: Observational Analysis of Patients with Diabetes and/or Hypertension Treated in the Clinical Practice Setting
A. I. El-Sakka et al.
JOURNAL OF INTERNATIONAL MEDICAL RESEARCH (2011)
Phosphodiesterase Type 5 (PDE5) Inhibitors in Erectile Dysfunction: The Proper Drug for the Proper Patient
Giovanni Corona et al.
JOURNAL OF SEXUAL MEDICINE (2011)
Guidelines on Male Sexual Dysfunction: Erectile Dysfunction and Premature Ejaculation
Konstantinos Hatzimouratidis et al.
EUROPEAN UROLOGY (2010)
Pharmacotherapy for Erectile Dysfunction
Ian Eardley et al.
JOURNAL OF SEXUAL MEDICINE (2010)
Is there a rationale for the chronic use of phosphodiesterase-5 inhibitors for lower urinary tract symptoms secondary to benign prostatic hyperplasia?
Thierry Roumeguere et al.
BJU INTERNATIONAL (2009)
The ENDOTRIAL Study: A Spontaneous, Open-Label, Randomized, Multicenter, Crossover Study on the Efficacy of Sildenafil, Tadalafil, and Vardenafil in the Treatment of Erectile Dysfunction
Emmanuele A. Jannini et al.
JOURNAL OF SEXUAL MEDICINE (2009)
Impairment of Couple Relationship in Male Patients with Sexual Dysfunction is Associated with Overt Hypogonadism
Giovanni Corona et al.
JOURNAL OF SEXUAL MEDICINE (2009)
Acceptance of and discontinuation rate from erectile dysfunction oral treatment in patients following bilateral nerve-sparing radical prostatectomy
Andrea Salonia et al.
EUROPEAN UROLOGY (2008)
The use of phosphodiesterase 5 inhibitors with concomitant medications
G. Corona et al.
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION (2008)
Giving patients with erectile dysfunction the opportunity to try all three available phosphodiesterase type 5 inhibitors contributes to better long-term treatment compliance
Christina Ljunggren et al.
JOURNAL OF SEXUAL MEDICINE (2008)
How long do patients with erectile dysfunction continue to use sildenafil citrate? Dropout rate from treatment course as outcome in real life
Yoshikazu Sato et al.
INTERNATIONAL JOURNAL OF UROLOGY (2007)
Phosphodiesterase type 5 inhibitors: The day after
Konstantinos Hatzimouratidis et al.
EUROPEAN UROLOGY (2007)
Is sex only for the healthy and wealthy?
Peter Stroberg et al.
JOURNAL OF SEXUAL MEDICINE (2007)
Patients responding to phosphodiesterase type 5 inhibitor therapy - What do their sexual partners know?
Theodor Klotz et al.
JOURNAL OF SEXUAL MEDICINE (2007)
Compliance of sildenafil treatment for erectile dysfunction and factors affecting it
BP Jiann et al.
INTERNATIONAL JOURNAL OF IMPOTENCE RESEARCH (2006)
Medication utilization behavior in patients receiving phosphodiesterase type 5 inhibitors for erectile dysfunction
JP Mulhall et al.
JOURNAL OF SEXUAL MEDICINE (2005)
Sexual experience of female partners of men with erectile dysfunction: The female experience of men's attitudes to life events and sexuality (FEMALES) study
WA Fisher et al.
JOURNAL OF SEXUAL MEDICINE (2005)
Why do patients with erectile dysfunction abandon effective therapy with sildenafil (Viagra (R))?
T Klotz et al.
INTERNATIONAL JOURNAL OF IMPOTENCE RESEARCH (2005)
Clinical efficacy of sildenafil citrate and predictors of long-term response
ML Gonzalgo et al.
JOURNAL OF UROLOGY (2003)
Long-term effect of sildenafil citrate on erectile dysfunction after radical prostatectomy: 3-year follow-up
R Raina et al.
UROLOGY (2003)
Lower urinary tract symptoms and male sexual dysfunction: The multinational survey of the aging male (MSAM-7)
R Rosen et al.
EUROPEAN UROLOGY (2003)
Incidence and determinants of sildenafil (dis)continuation: the Dutch cohort of sildenafil users
PC Souverein et al.
INTERNATIONAL JOURNAL OF IMPOTENCE RESEARCH (2002)
Efficacy, safety, and use of sildenafil in urologic practice
E Fagelman et al.
UROLOGY (2001)
Psychogenic erectile dysfunction - Classification and management
RC Rosen
UROLOGIC CLINICS OF NORTH AMERICA (2001)
Epidemiology of erectile dysfunction: results of the 'Cologne Male Survey'
M Braun et al.
INTERNATIONAL JOURNAL OF IMPOTENCE RESEARCH (2000)
Meta-analysis of observational studies in epidemiology - A proposal for reporting
DF Stroup et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2000)
Share Paper
